Fate Therapeutics's total assets for Q3 2025 were $343.67M, a decrease of ― from the previous quarter. FATE total liabilities were $109.61M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.